Concepedia

Polatuzumab vedotin–based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience

Yuwen Wang, Hsin‐An Hou, Feng‐Ming Tien, Jia‐Hau Liu, Wen‐Chien Chou, Bor‐Sheng Ko, Yu‐Wen Chen, Chien‐Chin Lin, Chieh‐Lung Cheng, Min‐Yen Lo,

Annals of Hematology · 2021 · 26 citations · 32 references

DOI

Concepts

References

32

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma

Sattva S. Neelapu, Frederick L. Locke, Nancy L. Bartlett et al. · New England Journal of Medicine · 2017 · 5.9K citations · Full text

, , +16

Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification

Bruce D. Cheson, Richard I. Fisher, Sally F. Barrington et al. · Journal of Clinical Oncology · 2014 · 5.6K citations · Full text

, , +17

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

Christine P. Hans · Blood · 2003 · 4.3K citations · Full text

, , +16

Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance

Norah A. Terrault, Anna S. Lok, Brian J. McMahon et al. · Hepatology · 2018 · 4.3K citations · Full text

, , +17

Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Stephen J. Schuster, Michael Bishop, Constantine S. Tam et al. · New England Journal of Medicine · 2018 · 4K citations · Full text

, , +15